학술논문

Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled Trial
Document Type
Article
Source
In: JAMA Network Open. (JAMA Network Open, 2024, :E2352830)
Subject
Language
English
ISSN
25743805